Physician profile
Ayaz Matin
NPI 1801087978
$8,420.51
in general payments reported to CMS, 2019-2025
15 companies · $2,072 in 2025
The $2,072 reported for 2025 was more than what 80% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $654 · 2020: $92.61 · 2021: $114 · 2022: $461 · 2023: $2,020 · 2024: $3,008 · 2025: $2,072.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,074 · Food and Beverage: $3,025.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,074.23 |
| Food and Beverage | $3,025.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,466.89 | 2019-2025 | Orise, Axios, Resolution 360 Clip |
| Olympus Corporation of The Americas | $409.30 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $373.48 | 2022-2024 | Dupixent |
| Fujifilm Healthcare Americas Corporation | $169.85 | 2024-2025 | Fujifilm |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $152.65 | 2025 | Lifevest |
| Nestle Healthcare Nutrition INC. | $124.74 | 2023 | |
| Genzyme Corporation | $124.01 | 2023 | |
| Allergan, INC. | $107.26 | 2019 | |
| Apollo Endosurgery US INC | $100.09 | 2023 | Overstitch Endoscopic Suturing System |
| Endogastric Solutions, INC | $96.18 | 2024 | Esophyx |
| Steris Corporation | $85.75 | 2025 | |
| Madrigal Pharmaceuticals | $79.17 | 2025 | Rezdiffra |
| Janssen Biotech, INC. | $56.99 | 2020 | |
| Erbe USA INC | $50.00 | 2019 | |
| Olympus America INC. | $24.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ayaz Matin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.